| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | NANTKWEST INC COM | 37,895 | 295,000 | 0.14% | ||
| 102 | AIMMUNE THERAPEUTICS INC COM | 19,501 | 293,000 | 0.14% | ||
| 103 | MACROGENICS INC | 9,762 | 292,000 | 0.14% | ||
| 104 | ULTRAGENYX PHARMACEUTICAL INC COM | 4,050 | 287,000 | 0.14% | ||
| 105 | IGNYTA INC COM | 44,599 | 281,000 | 0.14% | ||
| 106 | ALDER BIOPHARMACEUTICALS INC | 8,582 | 281,000 | 0.14% | ||
| 107 | ALNYLAM PHARMACEUTICALS INC | 4,078 | 276,000 | 0.13% | ||
| 108 | KITE PHARMA INCORPORATED | 4,889 | 273,000 | 0.13% | ||
| 109 | TG THERAPEUTICS INC COM | 35,297 | 273,000 | 0.13% | ||
| 110 | Atara Biotherapeutics Inc | 12,651 | 271,000 | 0.13% | ||
| 111 | NEUROCRINE BIOSCIE COM USD0.001 | 5,324 | 270,000 | 0.13% | ||
| 112 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 11,710 | 270,000 | 0.13% | ||
| 113 | CYTOKINETICS INC | 29,379 | 270,000 | 0.13% | ||
| 114 | LION BIOTECHNOLOGIES INC COM | 32,726 | 269,000 | 0.13% | ||
| 115 | LOXO ONCOLOGY INC COM | 10,231 | 268,000 | 0.13% | ||
| 116 | AKEBIA THERAPEUTICS INC | 29,590 | 268,000 | 0.13% | ||
| 117 | AGIOS PHARMACEUTICALS INC | 5,068 | 268,000 | 0.13% | ||
| 118 | Axovant Sciences LTD | 19,065 | 267,000 | 0.13% | ||
| 119 | IMMUNOMEDICS INCORPORATED | 81,010 | 263,000 | 0.13% | ||
| 120 | ADURO BIOTECH INC | 21,010 | 261,000 | 0.13% | ||
| 121 | TREVENA INC | 38,367 | 259,000 | 0.13% | ||
| 122 | BEIGENE LTD | 8,344 | 257,000 | 0.12% | ||
| 123 | SPDR S&P 500 ETF Call Opt 09/17 260.0 | 200 | 250,000 | 0.12% | Call | |
| 124 | ACCELERON PHARMA INC | 6,910 | 250,000 | 0.12% | ||
| 125 | TORONTO DOMINION BK ONT | 245,000 | 246,000 | 0.12% | ||
| 126 | AVEXIS INC COM | 5,869 | 242,000 | 0.12% | ||
| 127 | CELLDEX THERAPEUTICS INC NEW | 59,537 | 241,000 | 0.12% | ||
| 128 | ONCOMED PHARMACEUTICALS INC COM | 20,269 | 232,000 | 0.11% | ||
| 129 | NUSTAR ENERGY LP | 4,608 | 228,000 | 0.11% | ||
| 130 | ZIOPHARM ONCOLOGY INC | 40,175 | 226,000 | 0.11% | ||
| 131 | INOVIO PHARMACEUTICALS INC | 24,058 | 224,000 | 0.11% | ||
| 132 | PORTOLA PHARMACEUTICALS INC | 9,735 | 221,000 | 0.11% | ||
| 133 | ACHILLION PHARMACEUTICALS IN | 26,915 | 218,000 | 0.11% | ||
| 134 | OPHTHOTECH CORP | 4,702 | 217,000 | 0.10% | ||
| 135 | Esperion Therapeutics Inc | 15,540 | 215,000 | 0.10% | ||
| 136 | EPIZYME INC COM | 21,750 | 214,000 | 0.10% | ||
| 137 | CONCERT PHARMACEUTICALS INCORPORATED | 20,939 | 212,000 | 0.10% | ||
| 138 | GERON CORP | 91,851 | 208,000 | 0.10% | ||
| 139 | UNIQURE NV | 26,511 | 203,000 | 0.10% | ||
| 140 | SANGAMO THERAPEUTICS INCORPORATED | 41,249 | 191,000 | 0.09% | ||
| 141 | ADAPTIMMUNE THERAPEUTICS PLC | 26,974 | 190,000 | 0.09% | ||
| 142 | IMMUNOGEN INC | 70,796 | 190,000 | 0.09% | ||
| 143 | ONEOK INC NEW | 3,591 | 185,000 | 0.09% | ||
| 144 | SPECTRA ENERGY PARTNERS LP | 4,205 | 184,000 | 0.09% | ||
| 145 | JUNO THERAPEUTICS INC COM | 6,017 | 181,000 | 0.09% | ||
| 146 | DYNAVAX TECHNOLOGIES CORP | 17,302 | 181,000 | 0.09% | ||
| 147 | ISHARES TR | 1,986 | 179,000 | 0.09% | ||
| 148 | APPLIED GENETIC TECHNOL CORP | 16,223 | 159,000 | 0.08% | ||
| 149 | ISHARES U.S. UTILITIES ETF | 1,254 | 154,000 | 0.07% | ||
| 150 | REGULUS THERAPEUTICS INC COM | 46,269 | 153,000 | 0.07% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-022445, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
